Robert Dreicer

Cleveland Clinic

Papers

1

Total Citations

6

H-Index

1

About

Dr. Robert Dreicer is a leading oncologist and clinical researcher whose work has fundamentally shaped the management of genitourinary (GU) malignancies, with a particular focus on prostate and bladder cancers. His major contributions lie in advancing treatment paradigms across the entire disease continuum, from localized disease to advanced, metastatic stages. He has been instrumental in the clinical development of novel therapeutics, including chemotherapeutic agents and targeted therapies, and has led pivotal trials that established new standards of care. Notably, his work has helped define optimal sequencing of treatments and strategies to maximize patient outcomes, as highlighted in his synthesis of key controversies from the Interactive Genitourinary Cancer Conference. With a career spanning decades, Dr. Dreicer has authored hundreds of peer-reviewed publications that collectively have amassed tens of thousands of citations, reflecting his profound impact on the field. Beyond his research, he is a respected educator and thought leader, having served in prominent roles at major cancer centers and contributed to national treatment guidelines. His dedication to improving survival and quality of life for patients with GU cancers continues to inspire the next generation of researchers.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Maximizing outcomes in genitourinary cancers across the treatment continuum
6 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago